Moreover, the results of ROC analysis indicated that our transcriptional risk score had encouraging sensitivity and specificity for distinguishing IDH/1p19q subtypes, WHO grades, and particular pathology subtypes, especially for discrimination of astrocytoma from oligodendroglioma or mixed glioma (MG) (Figure 4D). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).